Slagle Financial LLC Increases Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Slagle Financial LLC raised its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 4.7% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 201,893 shares of the pharmacy operator’s stock after acquiring an additional 8,982 shares during the period. Slagle Financial LLC’s holdings in Walgreens Boots Alliance were worth $1,884,000 at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. denkapparat Operations GmbH acquired a new stake in shares of Walgreens Boots Alliance during the 4th quarter worth $97,000. Nomura Asset Management Co. Ltd. raised its stake in shares of Walgreens Boots Alliance by 0.6% in the 4th quarter. Nomura Asset Management Co. Ltd. now owns 274,656 shares of the pharmacy operator’s stock valued at $2,563,000 after purchasing an additional 1,696 shares in the last quarter. New Age Alpha Advisors LLC bought a new stake in shares of Walgreens Boots Alliance in the 4th quarter valued at approximately $3,949,000. Kiltearn Partners LLP grew its position in shares of Walgreens Boots Alliance by 12.6% during the 4th quarter. Kiltearn Partners LLP now owns 1,010,000 shares of the pharmacy operator’s stock valued at $9,423,000 after buying an additional 112,900 shares during the last quarter. Finally, Norges Bank bought a new stake in shares of Walgreens Boots Alliance in the 4th quarter worth approximately $58,241,000. Institutional investors and hedge funds own 58.59% of the company’s stock.

Walgreens Boots Alliance Stock Up 0.5 %

Shares of NASDAQ:WBA opened at $11.16 on Friday. Walgreens Boots Alliance, Inc. has a 52-week low of $8.08 and a 52-week high of $22.05. The company has a fifty day moving average of $10.86 and a 200-day moving average of $9.88. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64. The company has a market capitalization of $9.64 billion, a PE ratio of -1.09, a price-to-earnings-growth ratio of 1.31 and a beta of 0.62.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, beating the consensus estimate of $0.38 by $0.13. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The business had revenue of $39.50 billion for the quarter, compared to analysts’ expectations of $37.40 billion. During the same period in the prior year, the business posted $0.66 earnings per share. The firm’s revenue was up 7.6% on a year-over-year basis. On average, equities analysts predict that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on WBA. StockNews.com started coverage on Walgreens Boots Alliance in a report on Wednesday. They set a “hold” rating on the stock. Bank of America increased their target price on Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a report on Monday, January 13th. Truist Financial lowered their price target on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating on the stock in a report on Friday, January 31st. Royal Bank of Canada raised their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a “sector perform” rating in a research note on Wednesday, January 15th. Finally, Wolfe Research upgraded shares of Walgreens Boots Alliance to a “hold” rating in a research report on Monday, February 24th. Four equities research analysts have rated the stock with a sell rating, seven have given a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, Walgreens Boots Alliance has an average rating of “Hold” and a consensus price target of $10.59.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.